These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28079006)

  • 21. Formation of alginate microspheres produced using emulsification technique.
    Heng PW; Chan LW; Wong TW
    J Microencapsul; 2003; 20(3):401-13. PubMed ID: 12881119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium phosphate-alginate microspheres as enzyme delivery matrices.
    Ribeiro CC; Barrias CC; Barbosa MA
    Biomaterials; 2004 Aug; 25(18):4363-73. PubMed ID: 15046927
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fabrication of microparticle protein delivery systems based on calcium alginate.
    Yu CY; Jia LH; Cheng SX; Zhang XZ; Zhuo RX
    J Microencapsul; 2010; 27(2):171-7. PubMed ID: 19538029
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of partially cross-linked alginate used in the production of alginate microspheres by emulsification.
    Lee HY; Chan LW; Heng PW
    J Microencapsul; 2005 May; 22(3):275-80. PubMed ID: 16019913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microencapsulation of oils using sodium alginate.
    Chan LW; Lim LT; Heng PW
    J Microencapsul; 2000; 17(6):757-66. PubMed ID: 11063422
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mouse intranasal challenge model for potency testing of whole-cell pertussis vaccines.
    Queenan AM; Fernandez J; Shang W; Wiertsema S; van den Dobbelsteen GP; Poolman J
    Expert Rev Vaccines; 2014 Oct; 13(10):1265-70. PubMed ID: 25029905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Fabrication of alginate microsphere for controlled release and investigation of its release characteristics in vitro].
    He Q; Wen L; Li Q; Xu J; Luo F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Dec; 24(6):1301-4. PubMed ID: 18232481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outer Membrane Vesicles of Bordetella pertussis Encapsulated into Sodium Alginate Nanoparticles as Novel Vaccine Delivery System.
    Rami A; Kazemi-Lomedasht F; Mirjalili A; Noofeli M; Shahcheraghi F; Dounighi NM
    Curr Pharm Des; 2021; 27(42):4341-4354. PubMed ID: 34493192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and evaluation of mucinated sodium alginate microparticles for oral delivery of insulin.
    Builders PF; Kunle OO; Okpaku LC; Builders MI; Attama AA; Adikwu MU
    Eur J Pharm Biopharm; 2008 Nov; 70(3):777-83. PubMed ID: 18644444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model.
    Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M
    Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of pertussis serological potency test. Serological assessment of antibody response induced by whole cell vaccine as an alternative to mouse protection in an intracerebral challenge model.
    van der Ark A; van Straaten-van de Kappelle I; Akkermans A; Hendriksen C; van de Donk H
    Biologicals; 1994 Sep; 22(3):233-42. PubMed ID: 7811457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sodium alginate microspheres of metoprolol tartrate for intranasal systemic delivery: development and evaluation.
    Rajinikanth PS; Sankar C; Mishra B
    Drug Deliv; 2003; 10(1):21-8. PubMed ID: 12554360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alginate microparticles as novel carrier for oral insulin delivery.
    Reis CP; Ribeiro AJ; Neufeld RJ; Veiga F
    Biotechnol Bioeng; 2007 Apr; 96(5):977-89. PubMed ID: 17001630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alginate drug delivery systems: application in context of pharmaceutical and biomedical research.
    Jain D; Bar-Shalom D
    Drug Dev Ind Pharm; 2014 Dec; 40(12):1576-84. PubMed ID: 25109399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development, optimization and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery.
    Patil SB; Sawant KK
    J Microencapsul; 2009 Aug; 26(5):432-43. PubMed ID: 18932060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An oral DNA vaccine against infectious haematopoietic necrosis virus (IHNV) encapsulated in alginate microspheres induces dose-dependent immune responses and significant protection in rainbow trout (Oncorrhynchus mykiss).
    Ballesteros NA; Alonso M; Saint-Jean SR; Perez-Prieto SI
    Fish Shellfish Immunol; 2015 Aug; 45(2):877-88. PubMed ID: 26054788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Papain entrapment in alginate beads for stability improvement and site-specific delivery: physicochemical characterization and factorial optimization using neural network modeling.
    Sankalia MG; Mashru RC; Sankalia JM; Sutariya VB
    AAPS PharmSciTech; 2005 Sep; 6(2):E209-22. PubMed ID: 16353980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex.
    Mennini N; Furlanetto S; Cirri M; Mura P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):67-75. PubMed ID: 21864681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.